Furthermore, high CMIP levels were associated with worse prognosis (recurrence-free and overall survival) in gastric and breast cancers [43,45] and were related with herceptin resistance in HER2-positive gastric cancer cells [46]. This evidence concerns the gene CMIP and gastric cancer.